Skip to main content
OpenTrials
Completed

NCT Number: NCT03029663

Complications of Transurethral Resection of the Bladder Tumour

This is a prospective study enrolling consecutive patients who undergo transurethral resection of the bladder tumour (TURBT) aimed at determination of a safety of the procedure. Study end-points are incidence, severity and predictive factors of surgical complications. The study secondary aim is a validation of Clavien Dindo scoring system for reporting complication of TURBT.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary or recurrent bladder tumour
  • informed consent to undergo the surgery

Exclusion criteria

  • age <18 years

Treatment and study plan

Transurethral resection of the bladder tumour

Procedure

Primary outcomes

  1. Complications rate

    Time frame: 30 days postop

Secondary outcomes

  1. Complications severity

    Time frame: 30 days postop

    Severity of surgical complications according to Clavien-Dindo classification

Sponsors and collaborators

Lead sponsor

Medical University of Warsaw

Other

Registry information

Official study title

Complications of Transurethral Resection of the Bladder Tumour: A Prospective Analysis of Incidence and Predictive Factors

Acronym: ComTUR

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jan 24, 2017
Registry last updated
Dec 28, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.